Biodexa Pharmaceuticals (BDRX) Non Operating Interest Expenses (2013 - 2026)
Biodexa Pharmaceuticals (BDRX) recorded Non Operating Interest Expenses of -$83,184 in the quarter ended Jun 30, 2026, compared with -$180,096 a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Non Operating Interest Expenses (2013 - 2026) Analysis & Trends
On a TTM basis, Biodexa Pharmaceuticals' Non Operating Interest Expenses came in at -$505,744 as of Jun 30, 2026; for the year ended Dec 31, 2025, it came in at -$301,939.
- Across earlier years, Non Operating Interest Expenses came in at -$210,915 in the year ended Dec 31, 2024, -$50,997 in the year ended Dec 31, 2023, -$65,593 in the year ended Dec 31, 2022 and -$214,637 in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Non Operating Interest Expenses since the quarter ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biodexa Pharmaceuticals | 41.69 Mn | 18.48 Mn | - | -83,184.07 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83,184.07 |
| Dec 31, 2025 | -179,572.44 |
| Jun 30, 2025 | -180,096.17 |
| Dec 31, 2024 | -62,891.59 |
| Jun 30, 2023 | -27,529.99 |
| Dec 31, 2022 | -28,150.28 |
| Dec 31, 2020 | -569,114.38 |
| Dec 31, 2019 | -124,715.32 |
| Dec 31, 2018 | -755,332.36 |
| Dec 31, 2017 | -75,676.90 |
| Dec 31, 2016 | -729,771.47 |
| Dec 31, 2015 | -251,903.43 |
| Dec 31, 2014 | -255,088.90 |
| Dec 31, 2013 | -623,343.21 |
API Access
Biodexa Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();